Cidara Therapeutics, Inc. (CDTX)
219.99
-0.30
(-0.14%)
USD |
NASDAQ |
Dec 10, 14:23
Cidara Therapeutics EPS Diluted (Quarterly): -3.096 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Bristol Myers Squibb Co. | 1.079 |
| Johnson & Johnson | 2.121 |
| Mersana Therapeutics, Inc. | -1.511 |
| Pfizer Inc. | 0.6197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.23M |
| Total Expenses (Quarterly) | 83.23M |
| Enterprise Value | 6.503B |
| Earnings Yield | -5.36% |
| Normalized Earnings Yield | -4.824 |